Literature DB >> 25164762

Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.

Jing Yang1, Yanli Liu1, Chengwen Xue1, Wei Yu1, Jian Zhang1, Chunhua Qiao2.   

Abstract

A series of Mannich base type derivatives of Glaucocalyxin A (GLA) were designed and prepared. The cytotoxicity of these compounds was evaluated against six tumor cell lines (SMMC-7721, B16, SGC-7901, A549, KB, HL-60). Most compounds exhibited potent antiproliferative effects with low micromolar IC50 values. Compound 1 with para methyl benzyl amine moiety and compound 16 with cyclohexylamine moiety displayed the highest inhibition efficacy. Significantly, the cytotoxicity of compound 1 was much lower than GLA against the normal human liver cell (HL-7702). The in vitro stability assay revealed that transformation of GLA to Mannich base type derivatives improved the compound stability in rat plasma. Finally, decomposition product analysis supported that compound 1 could act as a prodrug and release GLA in the intracellular environment.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antitumor; Glaucocalyxin A; Glaucocalyxin A derivatives; Prodrug; Structure activity relationship

Mesh:

Substances:

Year:  2014        PMID: 25164762     DOI: 10.1016/j.ejmech.2014.08.061

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Glaucocalyxin A inhibits the growth of liver cancer Focus and SMMC-7721 cells.

Authors:  Lisha Tang; Xiaofeng Jin; Xiaohui Hu; Xiaoding Hu; Zulong Liu; Long Yu
Journal:  Oncol Lett       Date:  2015-12-03       Impact factor: 2.967

2.  Protective effects of glaucocalyxin A on the airway of asthmatic mice.

Authors:  Si Chen; Ying Piao; Yilan Song; Zhiguang Wang; Jingzhi Jiang; Yihua Piao; Li Li; Chang Xu; Liangchang Li; Yongxue Chi; Guihua Jin; Guanghai Yan
Journal:  Open Med (Wars)       Date:  2022-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.